[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Exousia Pro [@Exousia_Pro](/creator/twitter/Exousia_Pro) on x XXX followers Created: 2025-07-17 17:26:24 UTC $MAJI - Dr. Marvin Hausman, our Consultant and Chairman of our SAB, is developing a white paper on exosome safety. This paper will leverage AI to analyze extensive historical exosome data. The insights gained from this analysis are intended to support future IND submissions to the FDA. Dr. Hausman recently engaged with FDA representatives at the American Society of Clinical Oncology (ASCO) Annual Meeting, where the agency expressed interest in integrating AI into future submissions.  XXXXX engagements  **Related Topics** [marvin](/topic/marvin) [$maji](/topic/$maji) [Post Link](https://x.com/Exousia_Pro/status/1945897889919828163)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Exousia Pro @Exousia_Pro on x XXX followers
Created: 2025-07-17 17:26:24 UTC
$MAJI - Dr. Marvin Hausman, our Consultant and Chairman of our SAB, is developing a white paper on exosome safety. This paper will leverage AI to analyze extensive historical exosome data. The insights gained from this analysis are intended to support future IND submissions to the FDA. Dr. Hausman recently engaged with FDA representatives at the American Society of Clinical Oncology (ASCO) Annual Meeting, where the agency expressed interest in integrating AI into future submissions.
XXXXX engagements
/post/tweet::1945897889919828163